Home
>
National Drug Code (NDC)
>
Galantamine
Galantamine - 0615-7542-39 - (Galantamine)
Drug Information of Galantamine
| Product NDC: | 0615-7542 |
| Proprietary Name: | Galantamine |
| Non Proprietary Name: | Galantamine |
| Active Ingredient(s): | 8 mg/1 & nbsp; Galantamine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Galantamine
| Product NDC: | 0615-7542 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077590 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090529 |
Package Information of Galantamine
| Package NDC: | 0615-7542-39 |
| Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7542-39) |
NDC Information of Galantamine
| NDC Code | 0615-7542-39 |
| Proprietary Name | Galantamine |
| Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7542-39) |
| Product NDC | 0615-7542 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Galantamine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090529 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | GALANTAMINE HYDROBROMIDE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
